Randomized Active-Controlled Phase II Study of Denosumab Efficacy and Safety in Patients With Breast Cancer-Related Bone Metastases - Concepedia

Concepedia

Publication | Closed Access

Randomized Active-Controlled Phase II Study of Denosumab Efficacy and Safety in Patients With Breast Cancer-Related Bone Metastases

382

Citations

27

References

2007

Year

Allan Lipton, Guenther G. Steger, Jazmín Meneses Figueroa, Cristina Alvarado, Philippe Solal‐Céligny, Jean-Jacques Body, Richard de Boer, Rossana Berardi, Pere Gascón, Katia Tonkin,

Journal of Clinical Oncology

Abstract

Subcutaneous denosumab may be similar to IV BPs in suppressing bone turnover and reducing SRE risk. The safety profile was consistent with an advanced breast cancer population receiving systemic therapy.

References

	Year	Citations

Page 1